Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Cole

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT CohortElena J Ladas, Traci M Blonquist, Maneka Puligandla, et al.
Pediatric Blood & Cancer|August 12, 2024
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohortRahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2011
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M Vrooman, Donna S Neuberg, Kristen E Stevenson, et al.
Hospital Pediatrics|January 19, 2024
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address DisparitiesKristine A Karvonen, Puja J Umaretiya, Victoria B Koch, et al.
Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.
Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.
Pediatric Blood & Cancer|April 26, 2018
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaMaria Luisa Sulis, Traci M Blonquist, Kristen E Stevenson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 4, 2025
Treatment-related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration During Therapy for Childhood Acute Lymphoblastic LeukemiaYongkyu Park, Nirajan K C, Jeremy Willekens, et al.
Blood|December 17, 2009
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemiaLewis B Silverman, Jeffrey G Supko, Kristen E Stevenson, et al.
Pediatric Blood & Cancer|November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT CohortElena J Ladas, Traci M Blonquist, Maneka Puligandla, et al.
Pediatric Blood & Cancer|August 12, 2024
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohortRahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2011
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M Vrooman, Donna S Neuberg, Kristen E Stevenson, et al.
Hospital Pediatrics|January 19, 2024
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address DisparitiesKristine A Karvonen, Puja J Umaretiya, Victoria B Koch, et al.
Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.
Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.
Pediatric Blood & Cancer|April 26, 2018
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaMaria Luisa Sulis, Traci M Blonquist, Kristen E Stevenson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 4, 2025
Treatment-related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration During Therapy for Childhood Acute Lymphoblastic LeukemiaYongkyu Park, Nirajan K C, Jeremy Willekens, et al.
Blood|December 17, 2009
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemiaLewis B Silverman, Jeffrey G Supko, Kristen E Stevenson, et al.
Pediatric Blood & Cancer|November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.
Pageof 11